نتایج جستجو برای: innovative therapy

تعداد نتایج: 734130  

Journal: :Cytokine & Growth Factor Reviews 2017

Journal: :Medical law review 2013
Tracey Evans Chan

Developments in medical technology, healthcare delivery, and commercial interests in medicine have increased both the potential for conflicts of interest on the part of physicians, and doubts over the sufficiency of patient autonomy as a justification for administering innovative therapy. The legal and regulatory treatment of innovative therapy is therefore an important question, on which there...

2014
Rajsi Jain Praveen Kudva Rakesh Kumar

Periodontal disease is a multifactorial disease associated with destruction of supporting periodontal tissues of the tooth caused by certain periodontopathogenic species of bacteria or their toxic products by means of a biofilm formation. The conventional methods to treat periodontal diseases are the mechanical removal of the biofilm and adjunctive use of antibacterial disinfectants or various ...

Journal: :Clinical and experimental rheumatology 2002
C C Geilen C E Orfanos

Psoriasis is one of the most common skin diseases. A variety of molecular alterations has been identified in the active, lesional epidermis and dermis of psoriasis, but the pathogenesis still remains unexplained. Therefore, all antipsoriatic therapeutic regimens are symptomatic. Although there is no cure for psoriasis, a variety of therapeutic modalities is available to reduce the severity and ...

2017
Isabelle Vivodtzev

© Annals of Joint. All rights reserved. Ann Joint 2017;2:23 aoj.amegroups.com Muscle weakness and decreased functional capacity are common after knee surgery. Recovery duration and success strongly depend on post-surgery rehabilitation. Although neuromuscular electrical stimulation (NMES) therapy has been used for more than 30 years for muscle rehabilitation and strengthening after orthopedic s...

2005
Antoni Dávalos Michael Krams Donald A. Berry

More than 74 0001 patients with acute ischemic stroke have been randomized into clinical trials over the past 35 years to investigate new therapies.1 Only one treatment, thrombolysis with recombinant tissue plasminogen activator, has emerged from these investigations.2 Efforts to establish acute neuroprotectant therapies have yet to succeed.3,4 Have we squandered our resources? Has methodologic...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید